Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: Adenosine vs. Diltiazem [Phase 4]

View source ↗

Summary

Phase 4 trial comparing adenosine versus diltiazem in supraventricular tachycardia and atrioventricular nodal reentrant tachycardia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenosine (Adenosine)
  • Diltiazem (diltiazem)

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Supraventricular Tachycardia (SVT), Atrioventricular Nodal Re Entrant Tachycardia | Phase 4 | Status: COMPLETED